{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:52:49Z","timestamp":1791348769143,"version":"4.3.1"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Neurol"],"published-print":{"date-parts":[[2011,9,1]]},"abstract":"Background<\/jats:title>Myotonic dystrophy type 2 (DM2) is a recently discovered adult muscular dystrophy. Similar to DM1, this disease causes progressive debilitating weakness, clinical myotonia, and early cataracts and is thought to cause widespread physiologic dysfunction of multiple organ systems.<\/jats:p><\/jats:sec>Objective<\/jats:title>To analyze and compile the laboratory abnormalities of patients with DM2.<\/jats:p><\/jats:sec>Design<\/jats:title>Baseline DM2 laboratory data were compiled representing 68 different types of laboratory tests and 1442 total studies.<\/jats:p><\/jats:sec>Setting<\/jats:title>University medical center.<\/jats:p><\/jats:sec>Patients<\/jats:title>Eighty-three adults with genetically confirmed or clinically probable DM2 were identified. Of these patients, 49 had documented baseline laboratory screening.<\/jats:p><\/jats:sec>Main Outcome Measures<\/jats:title>The individual frequencies of abnormal laboratory values in the population with DM2 studied.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 1442 studies, results for 359 (24.9%) were outside of their standard reference ranges. Of the 68 types of laboratory tests studied, 43 had values from 15 or more different patients with DM2. The relative frequency of an abnormally elevated laboratory value was greater than 50% in several tests, including the levels of creatine kinase, total cholesterol, lactate dehydrogenase, and alanine aminotransferase. In addition, serum levels of IgG were low in 75% of all patients with DM2 tested, and absolute lymphocyte counts were low in 54% of all patients with DM2 tested.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>There is a high frequency of laboratory abnormalities in patients with DM2. These abnormalities provide insight into the widespread pathologic manifestations of DM2 and may form a basis for clinical monitoring and disease screening.<\/jats:p><\/jats:sec>","DOI":"10.1001\/archneurol.2011.191","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T20:30:36Z","timestamp":1315859436000},"page":"1180","source":"Crossref","is-referenced-by-count":30,"title":["Laboratory Abnormalities in Patients With Myotonic Dystrophy Type 2"],"prefix":"10.1001","volume":"68","author":[{"given":"Chad","family":"Heatwole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Richard","family":"Moxley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ref-noc15009-1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Myotonic dystrophy with no trinucleotide repeat expansion.","volume":"35","author":"Thornton","year":"1994","journal-title":"Ann Neurol"},{"issue":"5531","key":"ref-noc15009-2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"issue":"4","key":"ref-noc15009-3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"ref-noc15009-4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.nmd.2006.03.010","article-title":"140th ENMC International Workshop: Myotonic dystrophy DM2\/PROMM and other myotonic dystrophies with guidelines on management.","volume":"16","author":"Udd","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"ref-noc15009-5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/archneur.63.8.1149","article-title":"Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1.","volume":"63","author":"Heatwole","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"ref-noc15009-6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archneur.1995.00540250029009","article-title":"Proximal myotonic myopathy: clinical features of a multisystem disorder similar to myotonic dystrophy.","volume":"52","author":"Ricker","year":"1995","journal-title":"Arch Neurol"},{"issue":"10","key":"ref-noc15009-7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00415-004-0590-1","article-title":"Myotonic dystrophy type 2 and related myotonic disorders.","volume":"251","author":"Meola","year":"2004","journal-title":"J Neurol"},{"issue":"5","key":"ref-noc15009-8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s004150050359","article-title":"Myotonic dystrophy and proximal myotonic myopathy.","volume":"246","author":"Ricker","year":"1999","journal-title":"J Neurol"},{"issue":"11","key":"ref-noc15009-9","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/jnnp.2008.156562","article-title":"Strong association between myotonic dystrophy type 2 and autoimmune diseases.","volume":"80","author":"Tieleman","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"ref-noc15009-10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/(ISSN)1097-4598","article-title":"Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.","volume":"31","author":"Merlini","year":"2005","journal-title":"Muscle Nerve"},{"issue":"3","key":"ref-noc15009-11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.nmd.2008.12.002","article-title":"Dysphagia is present but mild in myotonic dystrophy type 2.","volume":"19","author":"Tieleman","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"ref-noc15009-12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/WCO.0b013e3282ef6064","article-title":"Myotonic dystrophy: RNA-mediated muscle disease.","volume":"20","author":"Wheeler","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"5938","key":"ref-noc15009-13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1173110","article-title":"Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.","volume":"325","author":"Wheeler","year":"2009","journal-title":"Science"}],"container-title":["Archives of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/1107861\/noc15009_1180_1184_1678139652.32928.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T22:30:36Z","timestamp":1678141836000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/1107861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archneurol.2011.191","relation":{},"ISSN":["0003-9942"],"issn-type":[{"value":"0003-9942","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}